UBcare Past Earnings Performance
Past criteria checks 0/6
UBcare's earnings have been declining at an average annual rate of -24.3%, while the Healthcare Services industry saw earnings growing at 15.7% annually. Revenues have been growing at an average rate of 7.8% per year.
Key information
-24.3%
Earnings growth rate
-24.3%
EPS growth rate
| Healthcare Services Industry Growth | 16.7% |
| Revenue growth rate | 7.8% |
| Return on equity | 0.2% |
| Net Margin | -0.4% |
| Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Revenue & Expenses BreakdownBeta
How UBcare makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 154,041 | -557 | 70,856 | 1,663 |
| 30 Sep 23 | 149,917 | -3,036 | 70,443 | 1,142 |
| 30 Jun 23 | 146,488 | 680 | 66,099 | 776 |
| 31 Mar 23 | 140,348 | 3,400 | 62,116 | 364 |
| 31 Dec 22 | 133,343 | 4,386 | 57,000 | 289 |
| 30 Sep 22 | 127,996 | 7,274 | 54,890 | 0 |
| 30 Jun 22 | 120,320 | 6,519 | 52,805 | 0 |
| 31 Mar 22 | 114,735 | 5,914 | 48,936 | 51 |
| 31 Dec 21 | 111,762 | 12,450 | 46,410 | 0 |
| 30 Sep 21 | 107,276 | 6,280 | 43,753 | 0 |
| 30 Jun 21 | 106,438 | 7,615 | 42,413 | 0 |
| 31 Mar 21 | 104,626 | 10,073 | 42,883 | 0 |
| 31 Dec 20 | 104,804 | 5,731 | 41,610 | 0 |
| 30 Sep 20 | 107,416 | 8,939 | 42,833 | 0 |
| 30 Jun 20 | 108,755 | 7,634 | 42,167 | 0 |
| 31 Mar 20 | 111,696 | 8,032 | 40,866 | 0 |
| 31 Dec 19 | 110,853 | 6,888 | 41,824 | 0 |
| 30 Sep 19 | 110,055 | 9,274 | 41,133 | 0 |
| 30 Jun 19 | 108,164 | 9,019 | 41,301 | 0 |
| 31 Mar 19 | 104,978 | 8,307 | 40,532 | 0 |
| 31 Dec 18 | 99,898 | 7,123 | 39,653 | 0 |
| 30 Sep 18 | 95,324 | 4,828 | 37,442 | 0 |
| 30 Jun 18 | 89,887 | 4,085 | 36,429 | 0 |
| 31 Mar 18 | 85,240 | 3,352 | 34,805 | 0 |
| 31 Dec 17 | 82,091 | 3,560 | 34,175 | 0 |
| 30 Sep 17 | 76,635 | 4,243 | 32,879 | 0 |
| 30 Jun 17 | 73,812 | 5,346 | 31,757 | 0 |
| 31 Mar 17 | 69,891 | 4,752 | 31,441 | 0 |
| 31 Dec 16 | 68,244 | 5,133 | 30,294 | 0 |
| 31 Mar 16 | 62,225 | 5,426 | 28,836 | 0 |
| 31 Dec 15 | 59,431 | 4,871 | 28,507 | 0 |
| 30 Sep 15 | 56,170 | 3,146 | 27,895 | 0 |
| 30 Jun 15 | 52,613 | 2,732 | 28,322 | 0 |
| 31 Mar 15 | 52,447 | 2,181 | 28,858 | 0 |
| 31 Dec 14 | 55,763 | 2,885 | 29,116 | 0 |
| 30 Sep 14 | 63,875 | 4,202 | 28,714 | 0 |
| 30 Jun 14 | 65,365 | 2,812 | 30,719 | 0 |
| 31 Mar 14 | 64,764 | 1,146 | 31,919 | 0 |
| 31 Dec 13 | 65,531 | 56 | 33,357 | 0 |
| 30 Sep 13 | 69,027 | 2,176 | 36,228 | 0 |
| 30 Jun 13 | 66,509 | 1,941 | 35,384 | 0 |
Quality Earnings: A032620 is currently unprofitable.
Growing Profit Margin: A032620 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: A032620 is unprofitable, and losses have increased over the past 5 years at a rate of 24.3% per year.
Accelerating Growth: Unable to compare A032620's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: A032620 is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare Services industry (13.5%).
Return on Equity
High ROE: A032620 has a negative Return on Equity (0.17%), as it is currently unprofitable.